• Je něco špatně v tomto záznamu ?

Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health

I. Pavlovska, A. Polcrova, JI. Mechanick, J. Brož, MM. Infante-Garcia, R. Nieto-Martínez, GA. Maranhao Neto, S. Kunzova, M. Skladana, JS. Novotny, H. Pikhart, J. Urbanová, GB. Stokin, JR. Medina-Inojosa, R. Vysoky, JP. González-Rivas

. 2021 ; 13 (7) : . [pub] 20210708

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025385

Grantová podpora
CZ.1.05/1.1.00/02.0123 European Regional Development Fund
LQ1605 National Program of Sustainability II (MEYS CR)
CZ.02.1.01/0.0/0.0/16_019/0000868 ENOCH
NT13434-4/2012 Ministerstvo Zdravotnictví Ceské Republiky

In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.

2nd Department of Internal Medicine St Anne's University Hospital in Brno and Faculty of Medicine Masaryk University 65691 Brno Czech Republic

Center for Research in Diabetes Metabolism and Nutrition 2nd Department of Internal Medicine 3rd Faculty of Medicine University Hospital Královské Vinohrady 10000 Prague Czech Republic

Department of Epidemiology and Public Health University College London London WC1E6BT UK

Department of Global Health and Population Harvard TH Chan School of Public Health Harvard University Boston MA 02115 USA

Department of Health Support Faculty of Sport Studies Masaryk University 62500 Brno Czech Republic

Department of Internal Medicine Charles University 2nd Faculty of Medicine 10506 Prague Czech Republic

Department of Public Health Faculty of Medicine Masaryk University 62500 Brno Czech Republic

Division of Endocrinology Diabetes and Bone Disease Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Division of Preventive Cardiology Department of Cardiovascular Medicine Mayo Clinic Rochester MN 55905 USA

Foundation for Clinic Public Health and Epidemiology Research of Venezuela Barquisimeto 3001 Lara Venezuela

International Clinical Research Centre 65691 Brno Czech Republic

LifeDoc Health Memphis TN 38119 USA

Marriott Heart Disease Research Program Mayo Clinic Rochester MN 55905 USA

Research Centre for Toxic Compounds in the Environment Masaryk University 62500 Brno Czech Republic

The Marie Josée and Henry R Kravis Center for Cardiovascular Health at Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025385
003      
CZ-PrNML
005      
20241203101715.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu13072338 $2 doi
035    __
$a (PubMed)34371848
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pavlovska, Iuliia $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic $u Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
245    10
$a Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health / $c I. Pavlovska, A. Polcrova, JI. Mechanick, J. Brož, MM. Infante-Garcia, R. Nieto-Martínez, GA. Maranhao Neto, S. Kunzova, M. Skladana, JS. Novotny, H. Pikhart, J. Urbanová, GB. Stokin, JR. Medina-Inojosa, R. Vysoky, JP. González-Rivas
520    9_
$a In contrast to the decreasing burden related to cardiovascular disease (CVD), the burden related to dysglycemia and adiposity complications is increasing in Czechia, and local drivers must be identified. A comprehensive literature review was performed to evaluate biological, behavioral, and environmental drivers of dysglycemia and abnormal adiposity in Czechia. Additionally, the structure of the Czech healthcare system was described. The prevalence of obesity in men and diabetes in both sexes has been increasing over the past 30 years. Possible reasons include the Eastern European eating pattern, high prevalence of physical inactivity and health illiteracy, education, and income-related health inequalities. Despite the advanced healthcare system based on the compulsory insurance model with free-for-service healthcare and a wide range of health-promoting initiatives, more effective strategies to tackle the adiposity/dysglycemia are needed. In conclusion, the disease burden related to dysglycemia and adiposity in Czechia remains high but is not translated into greater CVD. This discordant relationship likely depends more on other factors, such as improvements in dyslipidemia and hypertension control. A reconceptualization of abnormal adiposity and dysglycemia into a more actionable cardiometabolic-based chronic disease model is needed to improve the approach to these conditions. This review can serve as a platform to investigate causal mechanisms and secure effective management of cardiometabolic-based chronic disease.
650    _2
$a adipozita $x etnologie $7 D050154
650    _2
$a dospělí $7 D000328
650    _2
$a kardiometabolické riziko $7 D000083202
650    _2
$a kardiovaskulární nemoci $x epidemiologie $x etiologie $7 D002318
650    _2
$a chronická nemoc $x epidemiologie $x etnologie $7 D002908
650    _2
$a diabetes mellitus 2. typu $x epidemiologie $x etnologie $7 D003924
650    _2
$a dieta $x škodlivé účinky $x etnologie $7 D004032
650    _2
$a dyslipidemie $x epidemiologie $x etnologie $7 D050171
650    _2
$a běloši $x statistika a číselné údaje $7 D044465
650    _2
$a stravovací zvyklosti $x etnologie $7 D005247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a porucha glukózové tolerance $x epidemiologie $x etnologie $7 D018149
650    _2
$a zdravotní gramotnost $7 D057220
650    _2
$a disparity zdravotního stavu $7 D054624
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x epidemiologie $x etnologie $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x epidemiologie $x etnologie $7 D024821
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x epidemiologie $x etnologie $7 D009765
650    _2
$a prediabetes $x epidemiologie $x etnologie $7 D011236
650    _2
$a prevalence $7 D015995
650    _2
$a sedavý životní styl $x etnologie $7 D057185
650    _2
$a sociální determinanty zdraví $x etnologie $7 D064890
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bartošková, Anna $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic $u Research Centre for Toxic Compounds in the Environment (RECETOX), Masaryk University, 62500 Brno, Czech Republic $7 mub20241225433
700    1_
$a Mechanick, Jeffrey I $u The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA $u Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
700    1_
$a Brož, Jan $u Department of Internal Medicine, Charles University Second Faculty of Medicine, 10506 Prague, Czech Republic
700    1_
$a Infante-Garcia, Maria M $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Barquisimeto 3001, Lara, Venezuela
700    1_
$a Nieto-Martínez, Ramfis $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Barquisimeto 3001, Lara, Venezuela $u Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, MA 02115, USA $u LifeDoc Health, Memphis, TN 38119, USA
700    1_
$a Maranhao Neto, Geraldo A $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic
700    1_
$a Kunzova, Sarka $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic
700    1_
$a Skladana, Maria $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic $u Second Department of Internal Medicine, St. Anne's University Hospital in Brno and Faculty of Medicine, Masaryk University, 65691 Brno, Czech Republic
700    1_
$a Novotny, Jan S $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic
700    1_
$a Pikhart, Hynek $u Research Centre for Toxic Compounds in the Environment (RECETOX), Masaryk University, 62500 Brno, Czech Republic $u Department of Epidemiology and Public Health, University College London, London WC1E6BT, UK
700    1_
$a Urbanová, Jana $u Center for Research in Diabetes, Metabolism and Nutrition, Second Department of Internal Medicine, Third Faculty of Medicine, University Hospital Královské Vinohrady, 10000 Prague, Czech Republic
700    1_
$a Stokin, Gorazd B $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic
700    1_
$a Medina-Inojosa, Jose R $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA $u Marriott Heart Disease Research Program, Mayo Clinic, Rochester, MN 55905, USA
700    1_
$a Vysoky, Robert $u Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $u Department of Health Support, Faculty of Sport Studies, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a González-Rivas, Juan P $u International Clinical Research Centre (ICRC), St Anne's University Hospital Brno (FNUSA), 65691 Brno, Czech Republic $u Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Barquisimeto 3001, Lara, Venezuela $u Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, Boston, MA 02115, USA
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 13, č. 7 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34371848 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20241203101711 $b ABA008
999    __
$a ok $b bmc $g 1714430 $s 1145892
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 7 $e 20210708 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a CZ.1.05/1.1.00/02.0123 $p European Regional Development Fund
GRA    __
$a LQ1605 $p National Program of Sustainability II (MEYS CR)
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000868 $p ENOCH
GRA    __
$a NT13434-4/2012 $p Ministerstvo Zdravotnictví Ceské Republiky
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...